Carmelo Laganà

503 total citations
21 papers, 266 citations indexed

About

Carmelo Laganà is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Carmelo Laganà has authored 21 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Hematology. Recurrent topics in Carmelo Laganà's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). Carmelo Laganà is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). Carmelo Laganà collaborates with scholars based in Italy and United States. Carmelo Laganà's co-authors include Manuela Priolo, Corrado Mammì, Andrea Riccio, Angela Sparago, Flavia Cerrato, Agostino Cortelezzi, Carlo Finelli, Francesco Nobile, Antonella Poloni and Sara Galimberti and has published in prestigious journals such as Blood, Gene and Human Genetics.

In The Last Decade

Carmelo Laganà

20 papers receiving 259 citations

Peers

Countries citing papers authored by Carmelo Laganà

Since Specialization

Citations

This map shows the geographic impact of Carmelo Laganà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmelo Laganà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmelo Laganà more than expected).

Fields of papers citing papers by Carmelo Laganà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmelo Laganà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmelo Laganà. The network helps show where Carmelo Laganà may publish in the future.

Co-authorship network of co-authors of Carmelo Laganà

This figure shows the co-authorship network connecting the top 25 collaborators of Carmelo Laganà. A scholar is included among the top collaborators of Carmelo Laganà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmelo Laganà. Carmelo Laganà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib 2017 ·Experimental Hematology ·Bruno Martino, Corrado Mammì, (unknown), (unknown), (unknown), Manuela Priolo, Maurizio Postorino, Giovanni Tripepi, Francesca Ronco, Carmelo Laganà, Caterina Musolino, Marianna Greco, Giorgio La Nasa, Giovanni Caocci	3
2	A Genetic Risk Score for Insulin Resistance Identify Patients with Chronic Myeloid Leukemia, Treated with Nilotinib, Developing Diabetes 2016 ·Blood ·Bruno Martino, (unknown), Caterina Alati, (unknown), Carmelo Laganà, Francesca Ronco, Corrado Mammì	1
3	NFIX mutations affecting the DNA-binding domain cause a peculiar overgrowth syndrome (Malan syndrome): A new patients series 2015 ·European Journal of Medical Genetics ·Fiorella Gurrieri, Maria Luigia Cavaliere, Anita Wischmeijer, (unknown), Giovanni Neri, Maria Antonietta Pisanti, (unknown), Carmelo Laganà, Manuela Priolo	15
4	On the Absence of Calreticulin (CALR) Mutations in Chronic Myeloprolierative Neoplasms (MPNs) with Splanchnic Venous Thrombosis (SVT): Experience from a Single Institution 2014 ·Blood ·Bruno Martino, Corrado Mammì, (unknown), (unknown), Francesca Ronco, Anna Grazia Recchia, (unknown), Caterina Alati, Esther Natalie Olíva, Carmelo Laganà, Fortunato Morabito	3
5	Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy 2013 ·Leukemia & lymphoma ·Esther Natalie Olíva, Roberto Latagliata, Carmelo Laganà, Massimo Breccia, Sara Galimberti, Fortunato Morabito, Antonella Poloni, Enrico Balleari, Agostino Cortelezzi, Giuseppe A. Palumbo, Grazia Sanpaolo, Antonio Volpe, Giorgina Specchia, Carlo Finelli, Maria Grazia D’Errigo, (unknown), Caterina Alati, Giuliana Alimena, Francesco Nobile, Maria Antonietta Aloe Spiriti	25
6	Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study 2012 ·Annals of Hematology ·Esther Natalie Olíva, Maria Cuzzola, Maria Antonietta Aloe Spiriti, Antonella Poloni, Carmelo Laganà, Carmela Rigolino, Fortunato Morabito, Sara Galimberti, Riccardo Ghio, Agostino Cortelezzi, Giuseppe A. Palumbo, Grazia Sanpaolo, Carlo Finelli, Alessandra Ricco, Antonio Volpe, (unknown), Massimo Breccia, Giuliana Alimena, Francesco Nobile, Roberto Latagliata	20
7	A peculiar mutation in the DNA-binding/dimerization domain of NFIX causes Sotos-like overgrowth syndrome: A new case 2012 ·Gene ·Manuela Priolo, Enrico Grosso, (unknown), (unknown), (unknown), (unknown), (unknown), Carmelo Laganà	25
8	Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome 2012 ·Molecular Genetics and Metabolism ·Manuela Priolo, Lucia Micale, Bartolomeo Augello, Carmela Fusco, (unknown), Paolo Prontera, (unknown), Elisa Biamino, Angelo Selicorni, Corrado Mammì, Carmelo Laganà, Leopoldo Zelante, Giuseppe Merla	18
9	Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy 2012 ·Blood ·Esther Natalie Olíva, Francesco Albano, Nicola Di Renzo, Vincenzo Pavone, (unknown), Fortunato Morabito, Attilio Guarini, Giuseppe Tarantini, Silvana Capalbo, Emilio Iannitto, Giovanni Quarta, Nicola Cascavilla, Pierfrancesco Tassone, Francesco Iuliano, (unknown), Paola Casieri, Carmelo Laganà, Francesco Nobile, Giorgina Specchia	1
10	Changes in RPS14 expression levels during lenalidomide treatment in Low‐ and Intermediate‐1‐risk myelodysplastic syndromes with chromosome 5q deletion 2010 ·European Journal Of Haematology ·Esther N. Oliva, Maria Cuzzola, Francesco Nobile, Francesca Ronco, Maria Grazia D’Errigo, Carmelo Laganà, Fortunato Morabito, Sara Galimberti, Agostino Cortelezzi, Maria Antonietta Aloe Spiriti, Giorgina Specchia, Antonella Poloni, Massimo Breccia, Riccardo Ghio, Carlo Finelli, Pasquale Iacopino, Giuliana Alimena, Roberto Latagliata	23
11	[Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F]. 2010 ·PubMed ·Angelo Famà, Angela Rago, (unknown), Chiara Marzano, Roberto Latagliata, Corrado Mammì, Carmelo Laganà, (unknown), (unknown), (unknown), Antonietta Ferretti, Massimo Breccia, Oliviero Riggio, Agostino Tafuri	1
12	Primary Immune Thrombocytopenia (ITP) Guidelines for Bone Marrow Aspirate Reduce the Diagnostic Rate of Myelodysplastic Syndromes 2010 ·Blood ·Iolanda Donatella Vincelli, Esther Natalie Olíva, Francesca Ronco, (unknown), Bianca Oliva, V Gatto, Carmelo Laganà, Maria Grazia D’Errigo, Francesco Nobile	0
13	MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment 2008 ·European Journal of Human Genetics ·Manuela Priolo, Angela Sparago, Corrado Mammì, Flavia Cerrato, Carmelo Laganà, Andrea Riccio	57
14	The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods 2008 ·Leukemia & lymphoma ·Eugenio Lucia, Bruno Martino, Corrado Mammì, Ernesto Vigna, Carla Mazzone, Massimo Gentile, (unknown), Maria Grazia Bisconte, (unknown), (unknown), Carmelo Laganà, Francesco Romeo, Antonino Neri, Francesco Nobile, Fortunato Morabito	6
15	Utility of the Clinical Practice of Admnistering Thrombophilic Screening and Antithrombotic Prophylaxis with Low-Molecular-Weight Heparin to Healthy Donors Treated with G-Csf for Mobilization of Peripheral Blood Stem Cells 2007 ·Tumori Journal ·Massimo Martino, (unknown), Vincenzo Oriana, Giuseppe Console, Tiziana Moscato, Corrado Mammì, Giuseppe Messina, (unknown), Giuseppe Irrera, (unknown), Vincenzo Lombardo, Carmelo Laganà, (unknown)	2
16	Malpuech syndrome: Broadening the clinical spectrum and molecular analysis by array-CGH 2006 ·European Journal of Medical Genetics ·Manuela Priolo, Roberto Ciccone, (unknown), (unknown), Carmelo Laganà, Orsetta Zuffardi	4
17	Reciprocal translocations: a trap for cytogenetists? 2005 ·Human Genetics ·Roberto Ciccone, Roberto Giorda, Giuliana Gregato, Renzo Guerrini, Sabrina Giglio, Romeo Carrozzo, María Clara Bonaglia, (unknown), Carmelo Laganà, Romano Tenconi, Mariano Rocchi, Tiziano Pramparo, Orsetta Zuffardi, Elena Rossi	40
18	Identification of 14 rare marker chromosomes and derivatives by spectral karyotyping in prenatal and postnatal diagnosis 2004 ·American Journal of Medical Genetics Part A ·Paolo Guanciali‐Franchi, Giuseppe Calabrese, Elisena Morizio, Donatella Fantasia, Alessia Colosimo, Maria Michela Rinaldi, (unknown), (unknown), Fortunato Lonardo, (unknown), Adriana Zatterale, Carmelo Laganà, Liborio Stuppia, Giuseppe Sabatino, Giandomenico Palka	17
19	[Enema-induced intestinal perforation. A case report]. 2003 ·PubMed ·Mario Messina, (unknown), (unknown), Alberto Roggi, Carmelo Laganà	1
20	[Idiopathic constipation in children: 10-year experience]. 2000 ·PubMed ·Mario Messina, (unknown), (unknown), Alfredo Garzi, Carmelo Laganà, G Tota	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact